001     306606
005     20251129115931.0
024 7 _ |a 10.1016/j.celrep.2025.116589
|2 doi
024 7 _ |a pmid:41307996
|2 pmid
024 7 _ |a 2211-1247
|2 ISSN
024 7 _ |a 2639-1856
|2 ISSN
037 _ _ |a DKFZ-2025-02643
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Amon, Lukas
|b 0
245 _ _ |a GM-CSF and specific type 2 cytokines induce CD103+ and CD301b+ cell states in cDC1s and cDC2s.
260 _ _ |a Maryland Heights, MO
|c 2025
|b Cell Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1764338974_98055
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The heterogeneity of conventional dendritic cells type 1 (cDC1s) and type 2 (cDC2s) is well established, yet the identity and origin of CD301b+ cDC2s remain debated. Here, we show that CD301b+ cDC2s and CD103+ cDC1s develop from pre-committed progenitors in response to granulocyte/macrophage colony-stimulating factor (GM-CSF). While CD103+ cDC1s acquire their phenotype and functional properties through GM-CSF-driven differentiation from pre-cDC1s, CD301b+ cDC2s emerge as cytokine-induced states from DC2- and DC3-committed progenitors. CD103+ cDC1s and CD301b+ cDC2s exhibit enhanced T cell priming capacities and distinct cytokine expression profiles upon GM-CSF exposure. In vivo, DC-intrinsic GM-CSF sensing is dispensable for acquiring CD103 and CD301b expression with the notable exception of lung DCs, while specific type 2 cytokines induce CD103 and CD301b ex vivo. These findings identify GM-CSF and specific type 2 cytokines as central regulators of cDC1 and cDC2 effector differentiation and establish CD301b as a marker of a cytokine-driven cDC2 state.
536 _ _ |a 314 - Immunologie und Krebs (POF4-314)
|0 G:(DE-HGF)POF4-314
|c POF4-314
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a CD103(+) cDC1
|2 Other
650 _ 7 |a CD301b
|2 Other
650 _ 7 |a CD301b(+) cDC2
|2 Other
650 _ 7 |a CP: immunology
|2 Other
650 _ 7 |a DC2 and DC3 progenitor
|2 Other
650 _ 7 |a GM-CSF
|2 Other
650 _ 7 |a cell state
|2 Other
650 _ 7 |a conventional dendritic cells
|2 Other
650 _ 7 |a heterogeneity
|2 Other
650 _ 7 |a ontogeny
|2 Other
650 _ 7 |a type 2 cytokines
|2 Other
700 1 _ |a Vurnek, Damir
|b 1
700 1 _ |a Seichter, Anna
|b 2
700 1 _ |a Tchitashvili, Giorgi
|b 3
700 1 _ |a Kaszubowski, Tomasz
|b 4
700 1 _ |a Mroz, Markus
|b 5
700 1 _ |a Debeuf, Nincy
|b 6
700 1 _ |a Vogler, Tina
|b 7
700 1 _ |a Küpper, Nicole
|b 8
700 1 _ |a Rengarajan, Kaushikk Ravi
|b 9
700 1 _ |a Lächele, Lukas
|b 10
700 1 _ |a Tochoedo, Nounagnon R
|b 11
700 1 _ |a Baranska, Anna
|b 12
700 1 _ |a Autenrieth, Stella E
|0 P:(DE-He78)d3dbba28fe1239effd15962787cbc363
|b 13
|u dkfz
700 1 _ |a Nimmerjahn, Falk
|b 14
700 1 _ |a Hildner, Kai
|b 15
700 1 _ |a Pfeffer, Klaus
|b 16
700 1 _ |a Schraml, Barbara U
|b 17
700 1 _ |a Heger, Lukas
|b 18
700 1 _ |a Lambrecht, Bart N
|b 19
700 1 _ |a Lehmann, Christian H K
|b 20
700 1 _ |a Dudziak, Diana
|b 21
773 _ _ |a 10.1016/j.celrep.2025.116589
|g Vol. 44, no. 12, p. 116589 -
|0 PERI:(DE-600)2649101-1
|n 12
|p 116589
|t Cell reports
|v 44
|y 2025
|x 2211-1247
909 C O |o oai:inrepo02.dkfz.de:306606
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 P:(DE-He78)d3dbba28fe1239effd15962787cbc363
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-314
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Immunologie und Krebs
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-16
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CELL REP : 2022
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2023-05-02T08:49:39Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2023-05-02T08:49:39Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review
|d 2023-05-02T08:49:39Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-16
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-16
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b CELL REP : 2022
|d 2024-12-16
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2024-12-16
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2024-12-16
920 1 _ |0 I:(DE-He78)D431-20160331
|k D431
|l Dentritische Zellen bei Infektionen und Krebs
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)D431-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21